Reactions Weekly

, Volume 1695, Issue 1, pp 36–36 | Cite as

Anti CD19 CAR transduced T cells

Cytokine release syndrome: case report
Case report


  1. Tang X, et al. MVP combined with FC as lymphocyte-depleting chemotherapy before car-t treatment can reduce the incidence of severe cytokine release syndrome for relapsed/refractory all patients with high tumour burden. Blood 130 (Suppl. 1): Dec 2017. Available from: URL: [abstract] - China

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations